How has CONMED's derivative assets liabilities at fair value net changed year-over-year?

CONMED's derivative assets liabilities at fair value net increased by 262.0% year-over-year, from $671K to $2.43M.

What is the long-term trend for CONMED's derivative assets liabilities at fair value net?

Over 5 years (2020 to 2025), CONMED's derivative assets liabilities at fair value net has grown at a -28.4% compound annual growth rate (CAGR), from -$7.96M to -$1.5M.

CONMED CNMD Derivative Assets Liabilities At Fair Value Net

Derivative Assets Liabilities At Fair Value Net at other companies

Rumble, Inc.RUM

$9.2M—

Columbia Financial, Inc.CLBK

-$3M-173%

Evommune EVMN

$15.37K—

eBayEBAY

$27M-46.0%

Ladder CapitalLADR

$370K-20.8%

Golub CapitalGBDC

$0-100%

Other financials

Income statement

See full

Revenue$317.0M-1.3%

Gross profit$183.4M+3.2%

Operating income$25.4M+59.3%

Net income$13.8M+129%

EPS (diluted)$0.45+137%

Balance sheet

See full

Cash & equivalents$35.0M-1.3%

Total debt$862.6M-3.6%

Total equity$1.0B+4.1%

Total assets$2.3B+0.8%

Cash flow

See full

Operating cash flow$13.5M-67.6%

CapEx$2.9M-23.5%

Free cash flow$10.6M-72.0%

Valuation

See full

Market cap$1.04B-35.6%

Enterprise value$1.87B-24.5%

P/E19×+5.4×

P/S0.8×-0.5×

Profitability

See full

Gross margin55.2%-1.0pp

Operating margin8.2%-5.6pp

Net margin4%-5.0pp

FCF margin9%-3.5pp

Returns & leverage

See full

Return on equity5.5%-7.5pp

Debt / equity0.8×-0.1×

Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's derivative assets liabilities at fair value net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's derivative assets liabilities at fair value net?: CONMED (CNMD) reported derivative assets liabilities at fair value net of $2.43M in Q1 2026.
How has CONMED's derivative assets liabilities at fair value net changed year-over-year?: CONMED's derivative assets liabilities at fair value net increased by 262.0% year-over-year, from $671K to $2.43M.
What is the long-term trend for CONMED's derivative assets liabilities at fair value net?: Over 5 years (2020 to 2025), CONMED's derivative assets liabilities at fair value net has grown at a -28.4% compound annual growth rate (CAGR), from -$7.96M to -$1.5M.